These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

674 related items for PubMed ID: 19139383

  • 1. Anti-chlamydial antibiotic therapy for symptom improvement in peripheral artery disease: prospective evaluation of rifalazil effect on vascular symptoms of intermittent claudication and other endpoints in Chlamydia pneumoniae seropositive patients (PROVIDENCE-1).
    Jaff MR, Dale RA, Creager MA, Lipicky RJ, Constant J, Campbell LA, Hiatt WR.
    Circulation; 2009 Jan 27; 119(3):452-8. PubMed ID: 19139383
    [Abstract] [Full Text] [Related]

  • 2. Secondary prevention of atherosclerosis through chlamydia pneumoniae eradication (SPACE Trial): a randomised clinical trial in patients with peripheral arterial disease.
    Vainas T, Stassen FR, Schurink GW, Tordoir JH, Welten RJ, van den Akker LH, Kurvers HA, Bruggeman CA, Kitslaar PJ.
    Eur J Vasc Endovasc Surg; 2005 Apr 27; 29(4):403-11. PubMed ID: 15749042
    [Abstract] [Full Text] [Related]

  • 3. Results from a phase II multicenter, double-blind placebo-controlled study of Del-1 (VLTS-589) for intermittent claudication in subjects with peripheral arterial disease.
    Grossman PM, Mendelsohn F, Henry TD, Hermiller JB, Litt M, Saucedo JF, Weiss RJ, Kandzari DE, Kleiman N, Anderson RD, Gottlieb D, Karlsberg R, Snell J, Rocha-Singh K.
    Am Heart J; 2007 May 27; 153(5):874-80. PubMed ID: 17452167
    [Abstract] [Full Text] [Related]

  • 4. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease.
    Mohler ER, Hiatt WR, Creager MA.
    Circulation; 2003 Sep 23; 108(12):1481-6. PubMed ID: 12952839
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
    Rajagopalan S, Mohler ER, Lederman RJ, Mendelsohn FO, Saucedo JF, Goldman CK, Blebea J, Macko J, Kessler PD, Rasmussen HS, Annex BH.
    Circulation; 2003 Oct 21; 108(16):1933-8. PubMed ID: 14504183
    [Abstract] [Full Text] [Related]

  • 7. PoleStriding exercise and vitamin E for management of peripheral vascular disease.
    Collins EG, Edwin Langbein W, Orebaugh C, Bammert C, Hanson K, Reda D, Edwards LC, Littooy FN.
    Med Sci Sports Exerc; 2003 Mar 21; 35(3):384-93. PubMed ID: 12618567
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Quality of life and exercise performance after aortoiliac stent placement for claudication.
    Murphy TP, Soares GM, Kim HM, Ahn SH, Haas RA.
    J Vasc Interv Radiol; 2005 Jul 21; 16(7):947-53; quiz 954. PubMed ID: 16002502
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG, Gresele P, Ferrari G, Santoro L, Gianese F, Mesoglycan Intermittent Claudication Group.
    Thromb Haemost; 2001 Nov 21; 86(5):1181-7. PubMed ID: 11816704
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A randomized trial of iloprost in patients with intermittent claudication.
    Creager MA, Pande RL, Hiatt WR.
    Vasc Med; 2008 Feb 21; 13(1):5-13. PubMed ID: 18372433
    [Abstract] [Full Text] [Related]

  • 14. Oral buflomedil in the prevention of cardiovascular events in patients with peripheral arterial obstructive disease: a randomized, placebo-controlled, 4-year study.
    Limbs International Medicinal Buflomedil (LIMB) Study Group, Leizorovicz A, Becker F.
    Circulation; 2008 Feb 12; 117(6):816-22. PubMed ID: 18212283
    [Abstract] [Full Text] [Related]

  • 15. The Oslo balloon angioplasty versus conservative treatment study (OBACT)--the 2-years results of a single centre, prospective, randomised study in patients with intermittent claudication.
    Nylaende M, Abdelnoor M, Stranden E, Morken B, Sandbaek G, Risum Ø, Jørgensen JJ, Lindahl AK, Arnesen H, Seljeflot I, Kroese AJ.
    Eur J Vasc Endovasc Surg; 2007 Jan 12; 33(1):3-12. PubMed ID: 17055756
    [Abstract] [Full Text] [Related]

  • 16. Randomized controlled trial of supervised exercise to evaluate changes in cardiac function in patients with peripheral atherosclerotic disease.
    Hodges LD, Sandercock GR, Das SK, Brodie DA.
    Clin Physiol Funct Imaging; 2008 Jan 12; 28(1):32-7. PubMed ID: 18005078
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Improvement of the walking ability in intermittent claudication due to superficial femoral artery occlusion with supervised exercise and pneumatic foot and calf compression: a randomised controlled trial.
    Kakkos SK, Geroulakos G, Nicolaides AN.
    Eur J Vasc Endovasc Surg; 2005 Aug 12; 30(2):164-75. PubMed ID: 15890545
    [Abstract] [Full Text] [Related]

  • 20. Heparan sulfate in the treatment of intermittent claudication: results of a randomized, double-blind, placebo-controlled multicenter trial.
    Messa GL, Gelso E.
    Drugs Exp Clin Res; 2002 Aug 12; 28(1):37-48. PubMed ID: 12073766
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.